US05153U1079
US05153U1079
Aura Biosciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 678.23M EUR | 734.4M EUR | 429.17M EUR | 346.55M EUR |
Enterprise Value | 367.35M EUR | 683.16M EUR | 361.36M EUR | 304.42M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -3.22x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 2.15x | 2.33x | 4x | 2.53x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -2.68x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -8.3% | -14.07% | -21.35% | -17.79% |